WEBVTT 1 00:00:00.237 --> 00:00:02.520 One in every four adults will suffer a stroke 2 00:00:02.520 --> 00:00:03.780 in his life today. 3 00:00:03.780 --> 00:00:06.330 Neurological conditions like dementia and stroke, 4 00:00:06.330 --> 00:00:09.240 the rates are rising around the world. 5 00:00:09.240 --> 00:00:10.860 What in your view will help patients 6 00:00:10.860 --> 00:00:12.660 not fall through the cracks 7 00:00:12.660 --> 00:00:13.770 and actually get the help they need 8 00:00:13.770 --> 00:00:16.410 to maybe prevent this or recover? 9 00:00:16.410 --> 00:00:17.343 Prevention. 10 00:00:18.480 --> 00:00:19.413 Education. 11 00:00:20.790 --> 00:00:22.410 Recognizing the sign of a stroke, 12 00:00:22.410 --> 00:00:26.370 recognizing the sign of dementia, acting early, 13 00:00:26.370 --> 00:00:28.500 and new treatments on neuroplasticity 14 00:00:28.500 --> 00:00:30.240 like the one we bring to the market. 15 00:00:30.240 --> 00:00:31.650 One in every four adults 16 00:00:31.650 --> 00:00:33.630 will suffer a stroke in his life today. 17 00:00:33.630 --> 00:00:35.070 So it's definitely increasing 18 00:00:35.070 --> 00:00:37.410 and we see more and more strokes in the young. 19 00:00:37.410 --> 00:00:40.650 Now, there have been great advances in prevention 20 00:00:40.650 --> 00:00:42.930 in managing the risk factors, 21 00:00:42.930 --> 00:00:45.660 but still we see an increasing number of strokes, 22 00:00:45.660 --> 00:00:48.810 both in the young and with the aging population. 23 00:00:48.810 --> 00:00:52.964 Hyperacute care, i.e. removing the clots, the thrombolysis, 24 00:00:52.964 --> 00:00:55.650 the thrombectomy have made great advances 25 00:00:55.650 --> 00:00:58.110 but still reach only a fraction of the patients. 26 00:00:58.110 --> 00:00:59.760 In developed economies, we are probably 27 00:00:59.760 --> 00:01:02.820 less than 10% of the patients who are eligible 28 00:01:02.820 --> 00:01:05.730 and make it in time to the, to the center. 29 00:01:05.730 --> 00:01:09.090 So after the stroke, at the distance of the event, 30 00:01:09.090 --> 00:01:10.800 patients are left with a challenge 31 00:01:10.800 --> 00:01:12.780 of their recovery journey. 32 00:01:12.780 --> 00:01:16.500 Recovering their motor, their speech, their functions, 33 00:01:16.500 --> 00:01:18.450 and that's where we play a role 34 00:01:18.450 --> 00:01:22.080 in terms of providing therapies which act in conjunction 35 00:01:22.080 --> 00:01:25.680 with rehabilitation in providing better outcomes 36 00:01:25.680 --> 00:01:28.680 in achieving independence. 37 00:01:28.680 --> 00:01:29.670 When we talk about what you've done, 38 00:01:29.670 --> 00:01:32.610 you have taken NeuroAiD around the world, 39 00:01:32.610 --> 00:01:34.290 so many different health systems 40 00:01:34.290 --> 00:01:39.290 and had to really go under the scrutiny of regulators. 41 00:01:39.510 --> 00:01:43.950 If you could do it again, what would you do different 42 00:01:43.950 --> 00:01:46.080 given how that process was? 43 00:01:46.080 --> 00:01:48.300 So NeuroAiD is not the usual treatment, right? 44 00:01:48.300 --> 00:01:51.330 It emerged from, as a natural herbal product, 45 00:01:51.330 --> 00:01:54.210 as a very complex herbal extraction. 46 00:01:54.210 --> 00:01:56.190 We took the product as is, 47 00:01:56.190 --> 00:02:00.780 and we brought it through systematic preclinical research 48 00:02:00.780 --> 00:02:01.920 and clinical research. 49 00:02:01.920 --> 00:02:03.960 Today it's about 90 publications 50 00:02:03.960 --> 00:02:06.570 which document the properties of NeuroAiD. 51 00:02:06.570 --> 00:02:09.570 This is only valid because we did a huge effort 52 00:02:09.570 --> 00:02:10.953 in terms of CMC, 53 00:02:11.790 --> 00:02:14.340 something I learned late into the process. 54 00:02:14.340 --> 00:02:17.250 But having a herbal with nine ingredients, 55 00:02:17.250 --> 00:02:20.850 a very complex proprietary process of extraction, 56 00:02:20.850 --> 00:02:25.020 calibrating it so that each time the product is the same, 57 00:02:25.020 --> 00:02:27.450 the patient and the clinicians can expect 58 00:02:27.450 --> 00:02:30.360 the clinical benefit, but also the absence of drug, 59 00:02:30.360 --> 00:02:33.510 drug interaction is a very important work. 60 00:02:33.510 --> 00:02:35.580 When we talk about neuro restorative care, 61 00:02:35.580 --> 00:02:38.730 what do you think is gonna move it forward the quickest? 62 00:02:38.730 --> 00:02:42.810 Is it better access, better science, better tech? 63 00:02:42.810 --> 00:02:45.690 Where is that magic lever? 64 00:02:45.690 --> 00:02:48.270 For us, it's better science 65 00:02:48.270 --> 00:02:51.840 and acceptance that for very complex disease, 66 00:02:51.840 --> 00:02:54.390 the solution may not be in a single molecule, 67 00:02:54.390 --> 00:02:57.270 in a mono molecule religion. 68 00:02:57.270 --> 00:03:00.390 But for complex disease, pleiotropic mechanisms, 69 00:03:00.390 --> 00:03:04.140 acting at several points of the, of the disease 70 00:03:04.140 --> 00:03:08.100 helps achieving good outcomes in large heterogeneous 71 00:03:08.100 --> 00:03:09.570 groups of populations. 72 00:03:09.570 --> 00:03:10.530 Thank you so much. 73 00:03:10.530 --> 00:03:11.618 Thank you.